Overview Dividends

(NICE) Nice - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: US6536561086

AI Cloud Platform, Customer Engagement, Financial Crime, Compliance, Digital Evidence

EPS (Earnings per Share)

EPS CAGR: 17.52%
EPS Trend: 97.8%

Last SUE: 0.00σ
Qual. Beats: 0

Revenue

Revenue CAGR: 9.62%
Revenue Trend: 97.8%

Last SUE: 0.76σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	40.4%
Value at Risk 5%th	61.3%
Relative Tail Risk	-7.78%

Reward TTM
Sharpe Ratio	-1.00
Alpha	-51.60

Character TTM
Hurst Exponent	0.529
Beta	0.868
Beta Downside	0.878

Drawdowns 3y
Max DD	61.92%
Mean DD	24.71%
Median DD	28.92%

Description: NICE Nice November 03, 2025

NICE Ltd. (NASDAQ:NICE) delivers AI-driven cloud platforms that span three core verticals: customer experience (CXone Mpower), financial-crime compliance (Xceed and data-intelligence suites), and digital evidence management for the criminal-justice system (Evidencentral). The firm’s X-Sight platform targets high-end enterprise customers with a flexible AI-cloud stack, while its subscription-based model now generates roughly 80 % of total revenue, underscoring the shift toward recurring SaaS income.

Key performance indicators from FY 2023 show total revenue of about $1.5 billion, a year-over-year increase of 13 %, and a 28 % YoY growth in cloud-subscription ARR, reflecting strong demand for AI-enabled contact-center solutions. The global contact-center software market is projected to expand at a CAGR of ~23 % through 2029, driven by digital-first consumer expectations and the need for scalable automation.

Regulatory pressure on anti-money-laundering (AML) and fraud detection continues to accelerate adoption of NICE’s compliance suite, especially among mid-size financial institutions that are increasingly required to meet stricter reporting standards. Assuming the firm can sustain its R&D spend (≈15 % of revenue) to stay ahead of rapid AI advances, the upside potential remains tied to the broader AI-software adoption cycle.

For a deeper, data-driven assessment of NICE’s valuation and risk profile, you might explore the analytics platform ValueRay, which aggregates real-time financial metrics and peer benchmarks.

NICE Stock Overview

Market Cap in USD	6,490m
Sub-Industry	Application Software
IPO / Inception	1996-01-24
Return 12m vs S&P 500	-49.4%
Analyst Rating	4.33 of 5

NICE Dividends

Currently no dividends paid

NICE Growth Ratios

Metric	Value
CAGR 3y	-17.51%
CAGR/Max DD Calmar Ratio	-0.28
CAGR/Mean DD Pain Ratio	-0.71
Current Volume	1224.4k
Average Volume	714.2k

Piotroski VR‑10 (Strict, 0-10) 8.5

Net Income (561.1m TTM) > 0 and > 6% of Revenue (6% = 172.8m TTM)

FCFTA 0.14 (>2.0%) and ΔFCFTA 0.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 13.98% (prev 35.85%; Δ -21.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.15 (>3.0%) and CFO 786.4m > Net Income 561.1m (YES >=105%, WARN >=100%)

Net Debt (-331.2m) to EBITDA (815.6m) ratio: -0.41 <= 3.0 (WARN <= 3.5)

Current Ratio 1.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (63.2m) change vs 12m ago -2.59% (target <= -2.0% for YES)

Gross Margin 67.05% (prev 66.70%; Δ 0.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 55.71% (prev 50.82%; Δ 4.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 103.1 (EBITDA TTM 815.6m / Interest Expense TTM 6.11m) >= 6 (WARN >= 3)

Altman Z'' 6.18

(A) 0.08 = (Total Current Assets 1.38b - Total Current Liabilities 980.2m) / Total Assets 5.15b

(B) 0.52 = Retained Earnings (Balance) 2.70b / Total Assets 5.15b

(D) 2.99 = Book Value of Equity 3.86b / Total Liabilities 1.29b

Total Rating: 6.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 87.33

1. Piotroski 8.50pt

2. FCF Yield 11.63%

3. FCF Margin 24.70%

4. Debt/Equity 0.02

5. Debt/Ebitda -0.41

6. ROIC - WACC (= 3.33)%

7. RoE 15.29%

8. Rev. Trend 97.76%

9. EPS Trend 97.77%

What is the price of NICE shares?

As of November 25, 2025, the stock is trading at USD 105.40 with a total of 1,224,439 shares traded.
Over the past week, the price has changed by -12.79%, over one month by -20.33%, over three months by -25.06% and over the past year by -42.62%.

Is NICE a buy, sell or hold?

Nice has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy NICE.

Strong Buy: 10
Buy: 4
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the NICE price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	164	55.6%
Analysts Target Price	164	55.6%
ValueRay Target Price	86.5	-17.9%

NICE Fundamental Data Overview November 23, 2025

Market Cap USD = 6.49b (6.49b USD * 1.0 USD.USD)
P/E Trailing = 11.9443
P/E Forward = 8.5179
P/S = 2.253
P/B = 1.5929
P/EG = 0.8272
Beta = 0.289
Revenue TTM = 2.88b USD
EBIT TTM = 629.9m USD
EBITDA TTM = 815.6m USD
Long Term Debt = 86.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 12.8m USD (from shortTermDebt, last quarter)
Debt = 86.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -331.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.12b USD (6.49b + Debt 86.9m - CCE 455.9m)
Interest Coverage Ratio = 103.1 (Ebit TTM 629.9m / Interest Expense TTM 6.11m)
FCF Yield = 11.63% (FCF TTM 711.6m / Enterprise Value 6.12b)
FCF Margin = 24.70% (FCF TTM 711.6m / Revenue TTM 2.88b)
Net Margin = 19.48% (Net Income TTM 561.1m / Revenue TTM 2.88b)
Gross Margin = 67.05% ((Revenue TTM 2.88b - Cost of Revenue TTM 949.0m) / Revenue TTM)
Gross Margin QoQ = 66.81% (prev 66.75%)
Tobins Q-Ratio = 1.19 (Enterprise Value 6.12b / Total Assets 5.15b)
Interest Expense / Debt = 7.04% (Interest Expense 6.11m / Debt 86.9m)
Taxrate = 20.37% (37.1m / 181.9m)
NOPAT = 501.6m (EBIT 629.9m * (1 - 20.37%))
Current Ratio = 1.41 (Total Current Assets 1.38b / Total Current Liabilities 980.2m)
Debt / Equity = 0.02 (Debt 86.9m / totalStockholderEquity, last quarter 3.86b)
Debt / EBITDA = -0.41 (Net Debt -331.2m / EBITDA 815.6m)
Debt / FCF = -0.47 (Net Debt -331.2m / FCF TTM 711.6m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.89% (Net Income 561.1m / Total Assets 5.15b)
RoE = 15.29% (Net Income TTM 561.1m / Total Stockholder Equity 3.67b)
RoCE = 16.76% (EBIT 629.9m / Capital Employed (Equity 3.67b + L.T.Debt 86.9m))
RoIC = 12.49% (NOPAT 501.6m / Invested Capital 4.01b)
WACC = 9.16% (E(6.49b)/V(6.58b) * Re(9.21%) + D(86.9m)/V(6.58b) * Rd(7.04%) * (1-Tc(0.20)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.74% ; FCFE base≈694.3m ; Y1≈856.5m ; Y5≈1.46b
Fair Price DCF = 325.0 (DCF Value 20.07b / Shares Outstanding 61.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 97.77 | EPS CAGR: 17.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: 97.76 | Revenue CAGR: 9.62% | SUE: 0.76 | # QB: 0

Additional Sources for NICE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle